发明名称 SPIRO[PIPERIDINE-4,1`-PYRROLO[3,4-C]PYRROLE]
摘要 PURPOSE: A compound of formula 1 and pharmaceutically acceptable acid addition salt thereof are provided which is useful for treating mental disease, disorder of nerve system or disorder of physiological system. CONSTITUTION: In formula 1, R¬1 is C5-12 cyclo alkyl, decahydronaphthalene-1-yl, decahydronaphthalene-2-yl, indan-1-yl, indan-2-yl, decahydro-azylene-2-yl, bicyclo£6,2,0|dec-9-yl, acenaphtene-1-yl, bicyclo£3,3,1|non-9-yl, 2,3,-dihydro-1H-phenalene-1-yl, 2,3,3a,4,5,6-hexahydro-1H-phenalene-1-yl, octahydro-indene-2-yl, 1,2,3,4-tetrahydro-naphthalene-1-yl, 1,2,3,4-tetrahydro-naphthalene-2-yl, naphthalene-lower alkyl-2-yl or 5-isopropyl-2-methyl-bicyclo£3,1,0|hex-3-yl; R¬2 and R¬3 are H, hydroxy, lower alkyl, oxide or phenyl respectively; R¬4 is H, lower alkyl, -(CH2)nCH(OH)CF3, _(CH2)nC3-6-cycloalkyl, phenyl, benzyl, tetrahydrofurane-3-yl, -(CH2)nOC6H5, -(CH2)n mopolynyl, 3-methyl-occetane-3-yl-methyl, -(CH2)nCH2OH, -S(O2)heteroaryl, -C(O)heteroaryl, -S(O2)-phenyl, -S(O2)-N(lower alkyl)2, -C(O)-C3-6-cycloalkyl, -C(O)O-phenyl or -C(O)-O-lower alkyl; R¬5 is H, halogen, lower alkyl, trifluoromethyl or lower alkoxy; n is between 0 and 3.
申请公布号 KR20000006079(A) 申请公布日期 2000.01.25
申请号 KR19990021570 申请日期 1999.06.10
申请人 F. HOFFMANN-LA ROCHE AG 发明人 ADAM, GEO;DOUSENWERG, FRANK;KOHLCHEV, SKIJABINE;ROWER, STEPHAN;BICHMANN, WIRGEN
分类号 C07D401/14;A01N43/42;A61K31/00;A61K31/395;A61K31/435;A61K31/438;A61K31/44;A61K31/445;A61K31/505;A61K31/535;A61P3/04;A61P3/12;A61P9/12;A61P25/04;A61P25/08;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P43/00;C07D;C07D209/00;C07D221/00;C07D471/10;C07D471/20;C07D487/20;C07D498/10;C07D513/10;(IPC1-7):C07D401/14 主分类号 C07D401/14
代理机构 代理人
主权项
地址